As investors and industry alike try to read the tea leaves of what the upcoming change in administrations holds for the U.S., speculation abounds about what Trump 2.0 will mean for the biopharma and ...

An artificial intelligence-based tool developed by researchers in the U.K. is helping doctors identify people at risk of developing atrial fibrillation. Data from the ongoing Find-AF pilot study shows ...

Sangamo Therapeutics Inc.’s stock sank sharply on the last day of 2025 as Pfizer Inc. handed back the rights to their collaborative gene therapy hemophilia A program. While it was another big loss to ...

Copyright ©2024. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing Cookie Settings ...

From local drug discovery to global innovation, economic uncertainty is taking a toll on China’s innovative biotech system, ...

Ausperbio Therapeutics Inc. raised $110 million from two financing rounds in 2024 to advance its lead antisense ...

Driven by declining competitiveness, the new European Commission will start 2025 by getting to work on an EU-wide industrial ...

Daiichi Sankyo Co. Ltd.’s trophoblast cell surface antigen 2 (Trop2)-directed antibody-drug conjugate (ADC), datopotamab ...

Novel vaccines that can effectively target both coronaviruses and influenza viruses would be desirable to counteract the ...

Azole derivatives have been used as antifungal drugs in clinical practice for many years. However, limitations such as ...

Around the end of every year, the media reports on pregnancy and women who give birth on the last and first days of the new ...

Intriguing scientific data continue to roll out in the head and neck cancer space, where the need for therapies has spurred a number of drug firms to try new approaches, which BioWorld examines in ...